This page is part of the HL7 FHIR Implementation Guide: minimal Common Oncology Data Elements (mCODE) Release 1 - US Realm | STU1 (v2.0.0: STU 2) based on FHIR R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
{
"resourceType" : "MedicationRequest",
"id" : "cancer-related-medication-request-gefitinib",
"meta" : {
"profile" : [
"http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-cancer-related-medication-request"
]
},
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"cancer-related-medication-request-gefitinib\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-mcode-cancer-related-medication-request.html\">Cancer-Related Medication Request Profile</a></p></div><p><b>Procedure Intent Extension</b>: Curative - procedure intent <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#373808002)</span></p><p><b>status</b>: active</p><p><b>intent</b>: order</p><p><b>medication</b>: gefitinib 250 MG Oral Tablet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.0.0/CodeSystem-v3-rxNorm.html\">RxNorm</a>#349472)</span></p><p><b>subject</b>: <a href=\"Patient-cancer-patient-john-anyperson.html\">Patient/cancer-patient-john-anyperson</a> \" ANYPERSON\"</p><p><b>authoredOn</b>: 2019-04-01</p><p><b>requester</b>: <a href=\"Practitioner-us-core-practitioner-kyle-anydoc.html\">Practitioner/us-core-practitioner-kyle-anydoc</a> \" ANYDOC\"</p><p><b>reasonCode</b>: Non-small cell lung cancer (disorder) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#254637007)</span></p></div>"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-procedure-intent",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "373808002",
"display" : "Curative - procedure intent"
}
]
}
}
],
"status" : "active",
"intent" : "order",
"medicationCodeableConcept" : {
"coding" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "349472",
"display" : "gefitinib 250 MG Oral Tablet"
}
]
},
"subject" : {
"reference" : "Patient/cancer-patient-john-anyperson"
},
"authoredOn" : "2019-04-01",
"requester" : {
"reference" : "Practitioner/us-core-practitioner-kyle-anydoc"
},
"reasonCode" : [
{
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "254637007",
"display" : "Non-small cell lung cancer (disorder)"
}
]
}
],
"dosageInstruction" : [
{
"text" : "250mg orally once daily with or without food",
"timing" : {
"event" : [
"2019-04-01"
],
"repeat" : {
"boundsPeriod" : {
"start" : "2019-04-30"
},
"frequency" : 1,
"period" : 1,
"periodUnit" : "d"
},
"code" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-GTSAbbreviation",
"code" : "QD"
}
]
}
},
"route" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "26643006",
"display" : "Oral use"
}
]
},
"doseAndRate" : [
{
"doseQuantity" : {
"value" : 250,
"unit" : "mg",
"system" : "http://unitsofmeasure.org",
"code" : "mg"
}
}
]
}
]
}